Infliximab as a novel therapy for refractory Kawasaki disease
about
Kawasaki diseaseInfliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.Infliximab treatment for refractory kawasaki disease in korean children.Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmasUpdated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report.Management of Kawasaki disease.Recent understanding on diagnosis and management of central nervous system vasculitis in childrenReview: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
P2860
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
P2860
Infliximab as a novel therapy for refractory Kawasaki disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Infliximab as a novel therapy for refractory Kawasaki disease
@ast
Infliximab as a novel therapy for refractory Kawasaki disease
@en
Infliximab as a novel therapy for refractory Kawasaki disease
@nl
type
label
Infliximab as a novel therapy for refractory Kawasaki disease
@ast
Infliximab as a novel therapy for refractory Kawasaki disease
@en
Infliximab as a novel therapy for refractory Kawasaki disease
@nl
prefLabel
Infliximab as a novel therapy for refractory Kawasaki disease
@ast
Infliximab as a novel therapy for refractory Kawasaki disease
@en
Infliximab as a novel therapy for refractory Kawasaki disease
@nl
P2093
P1476
Infliximab as a novel therapy for refractory Kawasaki disease
@en
P2093
B Anne Eberhard
Beth S Gottlieb
Devyani Chowdhury
Jennifer E Weiss
P304
P407
P577
2004-04-01T00:00:00Z